In race to develop obesity drugs, Roche acquires California biotech for $2.7B

Please subscribe to IBJ to decode this article.

ch sS dir pn dtetooy.ani ar,echeCula glsu lw oiuhee aie m.tbLsetrloemrittd iiv , uElta aynyoodlnnpgektfr

Cei rfi.rSno7Movlineraibtidt ih leoalhcobutf gdcdsl bac n i,,aethdd tho-tu B aaegei sstG wshbnpeicts A nn aaaic za,read.bi$eRlisse atoqe2 eyiohygoiarairgnu e lnnondnl

h lTiT eoe usen-avdgrteaens fidnCtaai eonatsse ses eebdt. hoyeeoitt3,tiidsdrodv a-mnrleI ch uttknamcp.m a oco8esig epC md- euattsf rrau ntr nuwsh j-p T eelee tchroel,mp snmletti8o mnoacey a

t smsyl ndf b oesoesi cle i.tGeCkonhnesevRtteri saTeteng 0 rmt'ar uuwih oarr, nah,rihei lacsaesTeuhdich tah2e aa asre aleorsiu u0octtlhrdtRsstc ego b msdhnt,didsafm ,aend3ah titrot eoemo pe hae ph

dib nhyco,iyay att cpiant p raphuoxthmr fu ojdfsn ebselosn hPndrw dren ldlsrdL1sG erzue eesrde i.alp’nabetai hu,da osslegtos l tlMi l2-t eiedddtp aobisiI enZag ioesrdn-oeih chccnTlsue aeoLbiw leb

2rlPsolifto.aOe -1 ihsedar cdgi sosdyr ri cnhGaegeed s waivo e adltDlru a-ed,hm ckum ntNn ol Lyefetadhev bi pirthrasen gbb dekmt, ssdNiimsduer htoesyaioAk ocepW k aebwnzms o

tln x teaemhier3efhesho itcat g t4bfbe re als0oo ei syMpf lrs pctoa yeaucsu d genebhgasdrAotiineeinh a g gmbsaasolpaono eh iseno s tsd,as r eod ieasoiS o n tt,ne eA l er bhio essorn thnd% saset Uarxlrsaeiodu.idnv 0 todfruricfwlnt .evnln yoa yrlusfea etta hliehdwi

gkN rwoiocdoBrrwm,tt ni lafgutolldrig ph m.ld gti c’ mloaehlrfri hdvdaa aeb ofsabe ohn ntofuLestso ep h cusdiNthevhl dininapay aydndcakuroo is

meN ocsucuh i,q hhdamrkceaoopmhwbo neiuaewi he n tkohyd htreo kn nanphst eist rut saogatfbrfikauratae tei ttdasn u hcbntnssm sw telCi erRauscag.tre

n tgZypy‘ha towa”gl oeaoansT ihrdren khreoertisdaeacrprectdr-e,onesl eu htoourclnne bodatm skurea K’ri aa r f ale e“tsna hf,lt. agni phryetm i u Mn tofca

gtuP h 0 Toe.rieth0ooLvnl0d3a msei0a e at1 $he k cta G r,n0 h m 1-rpf 1ost$,

nieghasule bdymcooe eocma.n,tedcttai eh0n anfonlinlh mlend .stmoterdaen nodrs tlonhrCiic rvh ’te ytoriged ot0onloplot 0$rtn sot R goieoillfea im neofhid7mftplh,y o.nndnePef e 4or tteana tsl nde $TiennCe iaasnaani glbdllprmaihsts ret oncte sa wy c.ilaermss 2l uhcagabeoif,n0ha iheeasrttv ih la heuie2molraosecp8pU

ttehto o1saisbpudggiddeu9s ee,-g a-oruo2hnjdtn ta ,n o9di beny etnmolmeer-noie meaii 1atiei-r-r ah oisli e l8matht ediroay8 sl evpp twnCClantesca dn’ 6yab;go gpTs,crTtt-ricnre vtt nctteon 6 atage e pfenrosrs wt.rtrdleaeoetdt c LlhGCsed tdo mr e mwht dyepbroe afasinPeasltsatuti eetat ewei e oioalynibleeeutt

s .ksciitas. ld ossh inopR mstioi nicte ihros0shefhoat0ts,ic dta onel Dhra oiDerai itshaioe tlio to, n idehrooid avin nhitwanenrresa srefGe,cett y tespm,eo gn rasednn n tAb pu cepooho itftgahoAm gaRnner ic s’h ocdwmcfpt fssrteyonnsasbepnatorNeomalneRei04 aadeaIoii

p bns;&